Skip to main content
OpenTrials
Completed

NCT Number: NCT06276075

The Impact of Erigo®Pro Therapy and Motor Imagery on the Balance of Stroke Patients.

The aim of the study is to examine the impact of motor imagery, Erigo®Pro tilt table intervention, and classic rehabilitation on the balance of people after a stroke.

Completed

Looking for future studies?

Notify Me

Key information

Age range

38 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Military Institute of Medicine

Warsaw, Masovian District, 04-141, Poland

About this study

DESIGN: randomized observational study. SETTING: A hospital Rehabilitation Department. POPULATION: Sixty-six post-stroke patients mean, 64.85 ± 18.62 years. METHODS: 66 stroke patients were randomly assigned to three groups (22 people each) with different therapies (conventional, with the addition of Erigo®Pro and enriched with motor imagery). The therapy duration was two weeks. Patients underwent assessment before and after completion of therapy. The study used the Trunk Stability Test, Berg Balance Scale to assess balance, as well as the Riablo device to measure static balance. Additionally, an evaluation of the superficial tension of the transverse abdominis and multifidus muscles was conducted.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients 6-8 weeks post-stroke, 2) aged 38-85 years, mean, 3) males and females, 4) walking with or without assistance (modified Rankin scale = 3), 5) with slight neurological deficits (NIHSS ≤7).

Exclusion criteria

  • stroke up to six weeks after the episode, 2) epilepsy, 3) no possibility to sit and stand, 4) persistent deficit of speech and cognitive functions, lack of attention, 5) visual disturbances, 6) depression, 7) high or very low blood pressure, dizziness, malaise.

Treatment and study plan

Conventional rehabilitation, the Erigo®Pro table, motor imagery

Procedure

66 stroke patients were randomly assigned to three groups (22 people each) with different therapy (conventional, with the addition of Erigo®Pro and enriched with motor imagery). The therapy duration was two weeks. Patients underwent assessment before and after completion of therapy. The study used the Trunk Stability Test, Berg Balance Scale to assess balance, as well as the Riablo device to measure static balance. Additionally, an evaluation of the superficial tension of the transverse abdominis and multifidus muscles was conducted.

Primary outcomes

  1. Trunk Control Test

    Time frame: two weeks

    Assessment of trunk stability before and after therapy

  2. Berg Balance Scale

    Time frame: two weeks

    Assessment of body balance before and after therapy

  3. RiabloTM device

    Time frame: two weeks

    Assessment of static balance in the frontal plane before and after therapy

  4. RiabloTM device

    Time frame: two weeks

    Assessment of static balance in the sagittal plane before and after therapy

  5. Luna EMG

    Time frame: two weeks

    Assessment of the surface tension of the transverse abdominis muscle

  6. Luna EMG

    Time frame: two weeks

    Assessment of the surface tension of the multifidus muscle

Sponsors and collaborators

Lead sponsor

Anna Olczak

Other

Registry information

Official study title

The Influence of Therapy Enriched With the Erigo®Pro Table and Motor Imagery on the Body Balance of Patients After Stroke - a Randomized Observational Study.

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Feb 23, 2024
Registry last updated
Jan 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.